XML 41 R30.htm IDEA: XBRL DOCUMENT v3.24.0.1
Schedule II. Condensed Financial Information of Registrant
12 Months Ended
Dec. 31, 2023
Condensed Financial Information Disclosure [Abstract]  
Schedule II. Condensed Financial Information of Registrant

Schedule II. Condensed Financial Information of Registrant

AMERISAFE, INC.

CONDENSED BALANCE SHEETS

 

 

December 31,

 

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Assets:

 

 

 

 

 

 

Investments:

 

 

 

 

 

 

Fixed maturity securities—available-for-sale, at fair value
   (amortized cost $
24,309 and $19,824 in 2023 and 2022, respectively)

 

$

24,283

 

 

$

19,470

 

Equity securities, at fair value (cost $7,108 and $10,007 in 2023
   and 2022, respectively)

 

 

9,857

 

 

 

13,602

 

Short-term investments

 

 

 

 

 

10,145

 

Investment in subsidiaries

 

 

249,159

 

 

 

239,664

 

Total investments

 

 

283,299

 

 

 

282,881

 

Cash and cash equivalents

 

 

6,635

 

 

 

31,911

 

Deferred income taxes

 

 

880

 

 

 

982

 

Notes receivable from subsidiaries

 

 

1,925

 

 

 

1,855

 

Property and equipment, net

 

 

1,933

 

 

 

2,736

 

Federal income tax recoverable

 

 

784

 

 

 

543

 

Other assets

 

 

1,099

 

 

 

1,752

 

Total assets

 

$

296,555

 

 

$

322,660

 

Liabilities and shareholders’ equity

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

Accounts payable and other liabilities

 

 

4,104

 

 

 

5,228

 

Total liabilities

 

 

4,104

 

 

 

5,228

 

Shareholders' equity (net of Treasury stock of $36,929 and $34,758
   at December 31, 2023 and 2022, respectively)

 

 

292,451

 

 

 

317,432

 

Total liabilities and shareholders' equity

 

$

296,555

 

 

$

322,660

 

Schedule II. Condensed Financial Information of Registrant – (Continued)

AMERISAFE, INC.

CONDENSED STATEMENTS OF INCOME

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Revenues

 

 

 

 

 

 

 

 

 

Net investment income

 

$

4,861

 

 

$

2,395

 

 

$

896

 

Net unrealized gains (losses) on equity securities

 

 

(845

)

 

 

(490

)

 

 

2,590

 

Fee and other income

 

 

8,933

 

 

 

9,533

 

 

 

8,541

 

Total revenues

 

 

12,949

 

 

 

11,438

 

 

 

12,027

 

Expenses

 

 

 

 

 

 

 

 

 

Other operating costs

 

 

8,932

 

 

 

9,533

 

 

 

8,541

 

Total expenses

 

 

8,932

 

 

 

9,533

 

 

 

8,541

 

Income before income taxes and equity in earnings of subsidiaries

 

 

4,017

 

 

 

1,905

 

 

 

3,486

 

Income tax expense (benefit)

 

 

1,055

 

 

 

714

 

 

 

(1,188

)

Gain before equity in earnings of subsidiaries

 

 

2,962

 

 

 

1,191

 

 

 

4,674

 

Equity in net income of subsidiaries

 

 

59,146

 

 

 

54,411

 

 

 

61,083

 

Net income

 

$

62,108

 

 

$

55,602

 

 

$

65,757

 

Schedule II. Condensed Financial Information of Registrant – (Continued)

AMERISAFE, INC.

CONDENSED STATEMENTS OF CASH FLOWS

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Operating activities

 

 

 

 

 

 

 

 

 

Net cash provided by operating activities

 

$

5,591

 

 

$

6,121

 

 

$

6,622

 

Investing activities

 

 

 

 

 

 

 

 

 

Purchases of investments

 

 

(24,885

)

 

 

(31,909

)

 

 

(87,289

)

Proceeds from sales of investments

 

 

35,013

 

 

 

75,950

 

 

 

28,780

 

Purchases of property and equipment

 

 

(482

)

 

 

(1,903

)

 

 

(1,277

)

Dividends from subsidiary

 

 

56,000

 

 

 

77,700

 

 

 

148,400

 

Net cash provided by investing activities

 

 

65,646

 

 

 

119,838

 

 

 

88,614

 

Financing activities

 

 

 

 

 

 

 

 

 

Finance lease purchases

 

 

(91

)

 

 

(58

)

 

 

(44

)

Share-based compensation related tax withholding

 

 

(944

)

 

 

 

 

 

 

Purchase of treasury stock

 

 

(2,171

)

 

 

(12,388

)

 

 

 

Dividends to shareholders

 

 

(93,307

)

 

 

(100,427

)

 

 

(99,929

)

Net cash used in financing activities

 

 

(96,513

)

 

 

(112,873

)

 

 

(99,973

)

Change in cash and cash equivalents

 

 

(25,276

)

 

 

13,086

 

 

 

(4,737

)

Cash and cash equivalents at beginning of year

 

 

31,911

 

 

 

18,825

 

 

 

23,562

 

Cash and cash equivalents at end of year

 

$

6,635

 

 

$

31,911

 

 

$

18,825